• Policy
• Korea joined the COVID-19 vaccine development country
• by Lee, Hye-Kyung Jul 4, 2022 05:54am

• Policy
• Evusheld granted emergency use for preventing COVID-19
• by Lee, Hye-Kyung Jul 1, 2022 05:50am

• Policy
• Follow-up of impurity inspection
• by Lee, Hye-Kyung Jul 1, 2022 05:49am

• Policy
• Opdivo succeeded in setting the standard as the first treatm
• by Lee, Tak-Sun Jul 1, 2022 05:49am

• Policy
• SKY Covione is promoted the registration of the WHO EUL
• by Lee, Hye-Kyung Jul 1, 2022 05:49am

• Policy
• SK Bioscience gets final approval for SKYCovione
• by Lee, Hye-Kyung Jun 30, 2022 05:52am

• Policy
• ↑The cost of drugs for severe dz by ₩1.79 trillion
• by Lee, Tak-Sun Jun 29, 2022 05:53am

• Policy
• Fexclu reimb at ₩939, Kadcyla reimb extended from July
• by Kim, Jung-Ju Jun 29, 2022 05:53am

• Policy
• Low strength Esomezole Plus Tab priced same as Eso Duo
• by Lee, Tak-Sun Jun 28, 2022 06:09am

• Policy
• Phase 3 of Danicopan will be conducted in Korea
• by Lee, Hye-Kyung Jun 28, 2022 06:09am